Tag Archives: Mylan

Class Action Lawsuit Over EpiPen Pricing, Kickbacks Allowed to Proceed

January 25, 2021 By: Irvin Jackson
Generic EpiPens May Malfunction, Deliver Double Dose, FDA Warns

June 04, 2020 By: Russell Maas
EpiPen Problems May Lead To Premature Device Activation, FDA Warns

March 26, 2020 By: Russell Maas
Generic Axid Recall Issued Over Presence of Cancer-Causing Chemical NDMA

January 09, 2020 By: Irvin Jackson
Colon Cancer Lawsuit Filed Over Use Of Recalled Valsartan Products

February 01, 2019 By: Irvin Jackson
Valsartan Lawsuit Filed Over Liver Cancer, Esophageal Cancer from Recalled Hypertension Drug

January 16, 2019 By: Irvin Jackson
Lawsuit Over Valsartan Recall Filed Against Mylan

December 14, 2018 By: Irvin Jackson
EpiPen Auto-Injectors May Get Stuck In Carrier Tube, FDA Warns

November 05, 2018 By: Irvin Jackson
Use of Epinephrine To Save Cardiac Arrest Patients May Carry Neurological Risks: Study

September 05, 2018 By: Irvin Jackson
EpiPen Failures Caused At Least Seven Deaths This Year, According to FDA Data

November 03, 2017 By: Irvin Jackson

Judge Clears BioZorb Breast Marker Lawsuit To Move Forward, Rejecting Motion for Summary Judgment (Posted 5 days ago)

In a ruling likely to apply broadly across the litigation, a federal judge is refusing to dismiss a BioZorb marker lawsuit, clearing the way for other claims to move forward.

Bard PowerPort MDL Judge Allows More Time To Select Next Round of Bellwether Cases (Posted 7 days ago)

Lawyers are currently completing discovery in a group of 15 Bard PowerPort lawsuits, which will then be narrowed down to six potential trial claims by mid-April 2025.

Proposals for Hair Relaxer Bellwether Selection Protocol Submitted to MDL Judge (Posted 8 days ago)

Plaintiffs and defendants involved in hair relaxer lawsuits have filed competing plans which differ in how they would select 16 cases to serve as bellwether early test cases, and also differ in when they would be ready for trial.

Tag Archives: Mylan

Class Action Lawsuit Over EpiPen Pricing, Kickbacks Allowed to Proceed

Generic EpiPens May Malfunction, Deliver Double Dose, FDA Warns

EpiPen Problems May Lead To Premature Device Activation, FDA Warns

Generic Axid Recall Issued Over Presence of Cancer-Causing Chemical NDMA

Colon Cancer Lawsuit Filed Over Use Of Recalled Valsartan Products

Valsartan Lawsuit Filed Over Liver Cancer, Esophageal Cancer from Recalled Hypertension Drug

Lawsuit Over Valsartan Recall Filed Against Mylan

EpiPen Auto-Injectors May Get Stuck In Carrier Tube, FDA Warns

Use of Epinephrine To Save Cardiac Arrest Patients May Carry Neurological Risks: Study

EpiPen Failures Caused At Least Seven Deaths This Year, According to FDA Data

More Top Stories

Review A Case